Top 10: Global Pharma Companies

Pharmaceutical companies are diving into the increased need for scientific innovation, digital transformation and growing global healthcare demand.

As breakthroughs in areas such as oncology, immunology, gene therapy and AI-driven drug discovery accelerate, leading pharmaceutical firms are investing heavily in research, development and advanced technologies to deliver more effective treatments.

At the same time, companies face increasing pressure to improve patient access, navigate evolving regulatory requirements and address complex global health challenges.

Healthcare Digital explores the Top 10 Global Pharma Companies by revenue, highlighting the organisations shaping the future of medicine through innovation, scale and scientific excellence.

10. Bristol Myers Squibb 

Revenue: US$48.2bn

CEO: Christopher Boerner

Founded: 1989

Bristol Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for serious and difficult-to-treat diseases. 

The company is driven by bold science and a deep understanding of human biology, with research spanning oncology, immunology, cardiovascular disease and advanced therapeutic modalities such as cell therapy and protein degradation. 

Through a strategy that links target selection, translational research and clinical development, it aims to accelerate the delivery of transformational medicines to patients worldwide.

9. Sanofi

Revenue: US$50.7bn

CEO: Belén Garijo

Founded: 1973

A global R&D-driven, AI-powered biopharmaceutical company is Sanofi, focusing on improving people’s lives and delivering innovative medicines and vaccines worldwide. 

The company works to transform scientific discoveries into breakthrough therapies that address complex and immune-mediated diseases across immunology, oncology, neurology, rare diseases and vaccines. 

With a strong emphasis on innovation, sustainability and inclusion, Sanofi combines advanced research platforms with deep scientific expertise to accelerate drug development and improve patient access. 

8. Novartis

Revenue: US$54.5bn

CEO: Vas Narasimhan

Founded: 1996

Novartis is a leading global pharmaceutical company with a history spanning more than 250 years of scientific innovation and more than 30 years under its current name.

It is recognised for its role in advancing modern medicine by translating research breakthroughs into innovative treatments that improve and extend lives worldwide.

The company focuses on high-need therapeutic areas such as oncology, immunology, neuroscience and advanced technologies including gene and cell therapy. 

With operations in more than 100 countries and medicines reaching hundreds of millions of patients, Novartis plays a key role in the global healthcare system by delivering research-driven, patient-focused medicines at scale.

7. AstraZeneca

Revenue: US$58.7bn

CEO: Pascal Soriot

Founded: 1999

A global science-led pharmaceutical company focused on unlocking what science can do for people, society and the planet is AstraZeneca. 

Its purpose is to deliver life-changing medicines through research, innovation and collaboration, improving patient outcomes and quality of life. 

The company invests in oncology, rare disease and biopharmaceuticals, supported by global R&D centres and advanced data science including AI. 

Our values guide us to follow the science, put patients first, act responsibly and work inclusively across partnerships worldwide every single day.

6. AbbVie

Revenue: US$61.2bn

CEO: Robert Michael

Founded: 2013

AbbVie is a leading global biopharmaceutical company known for its patient-centered approach and commitment to advancing innovative medicines. 

Since becoming an independent company in 2013, AbbVie has focused on addressing complex health challenges through cutting-edge research and a robust development pipeline. 

Its therapies treat more than 75 conditions and reach approximately 60 million people annually across more than 175 countries. 

Driven by scientific excellence, integrity and innovation, AbbVie continues to develop transformative treatments that improve health outcomes and enhance the quality of life for patients around the world.

5. Pfizer

Revenue: US$62.6bn

CEO: Albert Bourla

Founded: 1849

Recognised for its commitment to change patients’ lives, Pfizer is one of the world’s leading pharmaceutical companies.

Since its founding in 1849, Pfizer has combined scientific innovation, advanced research and global collaboration to develop medicines and vaccines, addressing the world’s most significant health challenges. 

With a robust pipeline spanning oncology, vaccines, internal medicine and immunology, supported by thousands of scientists and extensive clinical research programs, Pfizer continues to advance life-changing treatments. 

The company remains dedicated to improving patient outcomes, expanding healthcare access and shaping the future of medicine.

4. Merck & Co / MSD

Revenue: US$65bn

CEO: Robert Davis

Founded: 1891

One of the world’s leading biopharmaceutical companies is MSD / Merck & Co, recognised for more than 130 years of scientific innovation and its commitment to improving human and animal health. 

Known as Merck & Co., Inc. in the United States and Canada, MSD develops innovative medicines, vaccines and health solutions that address some of the world’s most pressing health challenges, including cancer, HIV, hepatitis C, Alzheimer’s disease and infectious diseases. 

Through its research-driven approach, global collaborations and strong partnerships with healthcare systems, MSD continues to advance breakthrough treatments that help people and animals live longer, healthier lives.

3. Eli Lilly

Revenue: US$65.2bn

CEO: David Ricks

Founded: 1876

Eli Lilly is a leading pharmaceutical company, distinguished by its commitment to putting health above all and developing life-changing medicines for some of the most challenging diseases.

With more than 150 years of scientific innovation, more than 100 patented medicines and numerous industry-recognised achievements, Lilly has made significant advances in areas such as diabetes, obesity, cancer, Alzheimer’s disease, migraine, autoimmune disorders and dermatology.

The company combines cutting-edge research, high-quality manufacturing and patient-focused healthcare solutions to improve access to treatment and health education.

By continuously investing in breakthrough science and future technologies, Lilly remains a trusted global leader dedicated to helping people live healthier, longer and more fulfilling lives.

2. Roche

Revenue: US$78bn

CEO: Dr Thomas Schinecker

Founded: 1896

In second place is Roche, recognised due to its exceptional scientific innovation, integrated healthcare approach and longstanding commitment to improving patient outcomes.

Founded in Switzerland in 1896, Roche has grown into the world’s largest biotechnology company and a global leader in in-vitro diagnostics, uniquely combining diagnostics, medicines and digital solutions to prevent, stop and cure disease.

The company serves millions of patients in more than 100 countries and focuses on some of the most challenging areas of healthcare, including oncology, neurology, immunology, cardiovascular and metabolic diseases, ophthalmology and infectious diseases.

Roche’s pioneering work in personalised healthcare, precision diagnostics and targeted therapies has transformed the treatment of complex conditions and enabled more effective, individualised patient care.

With more than 100,000 employees worldwide, more than 125 years of scientific excellence and strategic investments in biotechnology, genomics and data-driven healthcare, Roche continues to shape the future of medicine and remains a trusted leader in global healthcare innovation.

1. Johnson & Johnson

Revenue: US$94.2bn

CEO: Joaquin Duato

Founded: 1886

Johnson & Johnson is regarded as one of the world’s top global pharmaceutical and healthcare companies because of its long history of innovation, scientific excellence and commitment to improving health outcomes worldwide.

For nearly 140 years, the company has pioneered groundbreaking advancements, from introducing some of the first mass-produced sterile surgical supplies to developing innovative medicines and medical technologies that address some of the most challenging diseases and conditions.

Through Johnson & Johnson Innovative Medicine, the company focuses on high-impact therapeutic areas including oncology, immunology, neuroscience and cardiopulmonary diseases, delivering treatments that have transformed and saved countless lives.

Its MedTech division complements this work by developing advanced technologies in cardiovascular care, orthopaedics, surgery and vision, helping make healthcare more precise, less invasive and more personalised.

With approximately 140,000 employees worldwide, a strong commitment to research and development and a patient-centered approach, Johnson & Johnson continues to lead the healthcare industry by driving innovation and improving the quality of life for people around the globe.